Clinical progress
Trial starts, data readouts and setbacks as companies report them.
Use caseBiotech
Biotech competitive intelligence, linked to the filing and the grant.
Follow developers, partners and competitors: clinical and regulatory news, public funding, patents, capital and licensing deals, each linked to its source and scored for how well the evidence supports it.
ForLife sciences investors, business development and competitive intelligence teams
RefreshDaily or weekly monitor runs
DeliveryBrief, report and data feed
See it run
One week with a biotech monitor.
One weekly run for an invented set of cell therapy developers, from sources to brief to your own tools.
What you receive
A brief like this, every week.
Each run reports only what changed, most material first. Every finding names its subject, says what happened and links to the record it came from.
Weekly brief · Monday 07:00Oncology cell therapy developers
4 material changes · 50 developers and partners
- CapitalVeritas Cell Therapeutics Inc
Registration statement filed for a planned share listing.
Source: SEC EDGAR95/100OmniaScoreHigh evidence - Public fundingArbor Bio Ltd
Awarded a grant to scale allogeneic cell manufacturing.
Source: UK Research and Innovation90/100OmniaScoreHigh evidence - TechnologyArbor Bio Ltd
Patent application published for a CAR construct targeting a solid tumour antigen.
Source: Espacenet86/100OmniaScoreHigh evidence - Clinical progressVeritas Cell Therapeutics Inc
Reported early phase 1 response data at a conference.
Source: Company announcement, corroborated by trade press74/100OmniaScoreStrong evidence
What a monitor tracks
The changes that move the decision.
Each monitor follows a defined universe of companies, places or technologies and reports what changed since the last run, with the source for every finding.
Regulatory
Approvals, designations and rejections published by regulators.
Public funding
UK research grants and US federal awards, including NIH funding.
Technology
Patent filings by company, target and modality.
Capital
Listings, funding rounds and current reports.
Partnerships and licensing
Licensing, collaboration and acquisition deals.
Where the evidence comes fromOfficial registers and datasets
PublisherUsed for
SEC EDGARRegistration statements, current reports and Form D notices
UK Research and InnovationInnovation grants and funded projects
USAspending.govUS federal awards, including NIH funding
EspacenetPatent filings across the UK, US and Europe
Companies HouseUK filings, share allotments and officers
Company announcements, regulators and trade pressFound by search and kept with their links
Questions a monitor answersExamples from this sector
Which competitors reported clinical data or a setback this month?
Who signed a licensing or collaboration deal in our modality?
Which companies filed patents on our target since the last review?
Who filed to list or raised capital this quarter?
Official source coverage is strongest in the UK, with US and European registers where listed. Company announcements, filings and trade press found by search are kept with their links. Every finding carries an OmniaScore: a deterministic 0 to 100 measure of how strongly the evidence supports it.
How it fits your week
From the register to your own tools.
The monitor runs on its own schedule. Your team reads the brief, checks the evidence where it matters and moves the findings into the tools it already uses.
- Monday 07:00The brief arrives
Email with a PDF attached: what changed across the competitive set since last week.
- Monday 09:00Check the evidence
Open a finding in the workspace and follow the link to the SEC filing it came from.
- As it happensAlert business development
A licensing deal sends a signed webhook, which your automation posts to Slack or Teams.
- Portfolio reviewPull it into the pack
Export the findings as CSV, or ask your AI assistant over MCP what changed at one competitor.
Email and PDF
The brief lands in the inbox of everyone on the monitor, with a PDF for committee packs.
Excel, Power BI or a warehouse
Findings export through the API as CSV or JSON Lines. Every row keeps its source link, date and OmniaScore.
CRM
Company records export in Attio's import format, or as CSV for Salesforce and HubSpot.
Slack, Teams or an internal system
A signed webhook announces each material change, so your automation can route it. We register the endpoint with you.
Claude, ChatGPT and other assistants
An MCP connection lets your team's AI assistant query the workspace and cite the findings.
Your own documents
Add private documents to a monitor, and they are read alongside the public sources.
Connect an AI assistant with the MCP setup guide. Read how private documents are stored and kept apart in Security and data handling.
How a pilot works
Prove value on one market first.
Start with a contained scope, measure the results, then extend coverage and delivery into the team's own tools.
- 01Define
Agree the market, the companies to follow and the questions that matter.
- 02Map
Build the initial universe and check it against the official registers.
- 03Monitor
Run daily or weekly, with a brief whenever something material changes.
- 04Review
Measure coverage, accuracy and analyst time saved before expanding.